Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine plus atazanavir/ritonavir or simplify to abacavir/lamivudine plus atazanavir Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

Published in

  • Journal of NeuroVirology

Time

Date/time value

  • 2019

Identity

Digital Object Identifier (DOI)

  • 10.1007/s13365-018-0680-y

Additional Document Info

Parent Title

  • JOURNAL OF NEUROVIROLOGY

Volume

  • 25

Issue

  • 1

Publisher

  • Taylor & Francis Ltd